Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
Clinical trial NCT03660761 · COMPLETED
Trial details
- NCT number
- NCT03660761
- Sponsor
- Rongjie Tao
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-03
- Primary completion
- 2017-01-03
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.